---
layout: default
title: Integrating Pathology and CT Imaging for Personalized Recurrence Risk Prediction in Renal Cancer
---

# Integrating Pathology and CT Imaging for Personalized Recurrence Risk Prediction in Renal Cancer

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2508.21581" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2508.21581v1</a>
  <a href="https://arxiv.org/pdf/2508.21581.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2508.21581v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2508.21581v1', 'Integrating Pathology and CT Imaging for Personalized Recurrence Risk Prediction in Renal Cancer')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: DaniÃ«l Boeke, Cedrik Blommestijn, Rebecca N. Wray, Kalina Chupetlovska, Shangqi Gao, Zeyu Gao, Regina G. H. Beets-Tan, Mireia Crispin-Ortuzar, James O. Jones, Wilson Silva, Ines P. Machado

**åˆ†ç±»**: cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-08-29

**å¤‡æ³¨**: 12 pages, 2 figures, 1 table. Accepted at the Multimodal Learning and Fusion Across Scales for Clinical Decision Support (ML-CDS) Workshop, MICCAI 2025. This is the submitted version with authors, affiliations, and acknowledgements included; it has not undergone peer review or revisions. The final version will appear in the Springer Lecture Notes in Computer Science (LNCS) proceedings

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºå¤šæ¨¡æ€èåˆæ–¹æ³•ä»¥æå‡è‚¾ç™Œå¤å‘é£é™©é¢„æµ‹ç²¾åº¦**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `å¤šæ¨¡æ€èåˆ` `æ·±åº¦å­¦ä¹ ` `è‚¾ç™Œ` `å¤å‘é£é™©é¢„æµ‹` `ç—…ç†å­¦` `è®¡ç®—æœºæ–­å±‚æ‰«æ` `ç”Ÿå­˜å»ºæ¨¡`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰çš„Leibovichè¯„åˆ†åœ¨æ‚£è€…çº§åˆ«çš„åˆ†è¾¨ç‡æœ‰é™ï¼Œä¸”æœªè€ƒè™‘å½±åƒä¿¡æ¯ï¼Œå¯¼è‡´å¤å‘é£é™©è¯„ä¼°ä¸è¶³ã€‚
2. æœ¬ç ”ç©¶æå‡ºäº†ä¸€ç§å¤šæ¨¡æ€èåˆæ–¹æ³•ï¼Œé€šè¿‡æ•´åˆCTå½±åƒå’Œç—…ç†WSIï¼Œåˆ©ç”¨æ·±åº¦å­¦ä¹ æ¡†æ¶è¿›è¡Œå¤å‘é£é™©é¢„æµ‹ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼ŒWSIæ¨¡å‹åœ¨æ€§èƒ½ä¸Šä¼˜äºCTæ¨¡å‹ï¼Œä¸­æœŸèåˆæ–¹æ³•è¿›ä¸€æ­¥æå‡äº†é¢„æµ‹ç²¾åº¦ï¼Œæ¥è¿‘ä¸´åºŠåŸºçº¿æ°´å¹³ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨é€æ˜ç»†èƒè‚¾ç»†èƒç™Œï¼ˆccRCCï¼‰ä¸­ï¼Œå¤å‘é£é™©è¯„ä¼°å¯¹æŒ‡å¯¼æœ¯åç›‘æµ‹å’Œæ²»ç–—è‡³å…³é‡è¦ã€‚å°½ç®¡Leibovichè¯„åˆ†å¹¿æ³›ç”¨äºåˆ†å±‚è¿œå¤„å¤å‘é£é™©ï¼Œä½†å…¶åœ¨æ‚£è€…çº§åˆ«çš„åˆ†è¾¨ç‡æœ‰é™ï¼Œå¹¶ä¸”æœªè€ƒè™‘å½±åƒä¿¡æ¯ã€‚æœ¬ç ”ç©¶é€šè¿‡æ•´åˆæœ¯å‰è®¡ç®—æœºæ–­å±‚æ‰«æï¼ˆCTï¼‰å’Œæœ¯åç»„ç»‡ç—…ç†å…¨åˆ‡ç‰‡å›¾åƒï¼ˆWSIsï¼‰ï¼Œè¯„ä¼°å¤šæ¨¡æ€å¤å‘é¢„æµ‹ã€‚é‡‡ç”¨æ¨¡å—åŒ–æ·±åº¦å­¦ä¹ æ¡†æ¶ï¼Œç»“åˆé¢„è®­ç»ƒç¼–ç å™¨å’ŒåŸºäºCoxçš„ç”Ÿå­˜å»ºæ¨¡ï¼Œæµ‹è¯•äº†å•æ¨¡æ€ã€æ™šæœŸèåˆå’Œä¸­æœŸèåˆè®¾ç½®ã€‚åœ¨çœŸå®çš„ccRCCé˜Ÿåˆ—ä¸­ï¼ŒåŸºäºWSIçš„æ¨¡å‹å§‹ç»ˆä¼˜äºä»…ä½¿ç”¨CTçš„æ¨¡å‹ï¼Œçªæ˜¾äº†ç—…ç†å­¦çš„é¢„åå¼ºåº¦ã€‚ä¸­æœŸèåˆè¿›ä¸€æ­¥æå‡äº†æ€§èƒ½ï¼Œæœ€ä½³æ¨¡å‹ï¼ˆTITAN-CONCHä¸ResNet-18ï¼‰æ¥è¿‘è°ƒæ•´åçš„Leibovichè¯„åˆ†ã€‚éšæœºå¹³å±€æ‰“ç ´ç¼©å°äº†ä¸´åºŠåŸºçº¿ä¸å­¦ä¹ æ¨¡å‹ä¹‹é—´çš„å·®è·ï¼Œè¡¨æ˜ç¦»æ•£åŒ–å¯èƒ½å¤¸å¤§ä¸ªä½“åŒ–æ€§èƒ½ã€‚é€šè¿‡ç®€å•çš„åµŒå…¥è¿æ¥ï¼Œæ”¾å°„å­¦ä¸»è¦é€šè¿‡èåˆå¢åŠ äº†ä»·å€¼ã€‚è¿™äº›å‘ç°å±•ç¤ºäº†åŸºäºåŸºç¡€æ¨¡å‹çš„å¤šæ¨¡æ€æ•´åˆåœ¨ä¸ªæ€§åŒ–ccRCCé£é™©é¢„æµ‹ä¸­çš„å¯è¡Œæ€§ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬ç ”ç©¶æ—¨åœ¨è§£å†³é€æ˜ç»†èƒè‚¾ç»†èƒç™Œï¼ˆccRCCï¼‰å¤å‘é£é™©è¯„ä¼°ä¸­ï¼Œç°æœ‰Leibovichè¯„åˆ†çš„å±€é™æ€§ï¼Œå°¤å…¶æ˜¯åœ¨æ‚£è€…çº§åˆ«åˆ†è¾¨ç‡å’Œå½±åƒä¿¡æ¯çš„ç¼ºå¤±é—®é¢˜ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šé€šè¿‡æ•´åˆæœ¯å‰CTå½±åƒå’Œæœ¯åç—…ç†WSIï¼Œé‡‡ç”¨æ·±åº¦å­¦ä¹ æ¡†æ¶è¿›è¡Œå¤šæ¨¡æ€å¤å‘é£é™©é¢„æµ‹ï¼Œä»¥æé«˜é¢„æµ‹çš„å‡†ç¡®æ€§å’Œä¸ªæ€§åŒ–æ°´å¹³ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šæ•´ä½“æ¶æ„åŒ…æ‹¬é¢„è®­ç»ƒçš„ç¼–ç å™¨å’ŒCoxç”Ÿå­˜æ¨¡å‹ï¼Œæµ‹è¯•äº†å•æ¨¡æ€ã€æ™šæœŸèåˆå’Œä¸­æœŸèåˆçš„ä¸åŒè®¾ç½®ï¼Œä»¥è¯„ä¼°å„è‡ªçš„æ€§èƒ½ã€‚

**å…³é”®åˆ›æ–°**ï¼šæœ¬ç ”ç©¶çš„ä¸»è¦åˆ›æ–°åœ¨äºä¸­æœŸèåˆç­–ç•¥çš„åº”ç”¨ï¼Œæ˜¾è‘—æå‡äº†æ¨¡å‹çš„é¢„æµ‹èƒ½åŠ›ï¼Œä¸”WSIæ¨¡å‹çš„è¡¨ç°ä¼˜äºä¼ ç»ŸCTæ¨¡å‹ï¼Œå±•ç¤ºäº†ç—…ç†å­¦åœ¨é¢„åè¯„ä¼°ä¸­çš„é‡è¦æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šé‡‡ç”¨ResNet-18ä½œä¸ºåŸºç¡€ç½‘ç»œç»“æ„ï¼Œç»“åˆéšæœºå¹³å±€æ‰“ç ´ç­–ç•¥ï¼Œä¼˜åŒ–äº†æ¨¡å‹çš„æ€§èƒ½è¯„ä¼°ï¼Œç¡®ä¿äº†å¤šæ¨¡æ€æ•°æ®çš„æœ‰æ•ˆèåˆã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœæ˜¾ç¤ºï¼ŒåŸºäºWSIçš„æ¨¡å‹åœ¨å¤å‘é£é™©é¢„æµ‹ä¸­è¡¨ç°ä¼˜äºCTæ¨¡å‹ï¼Œå°¤å…¶æ˜¯åœ¨ä¸­æœŸèåˆè®¾ç½®ä¸‹ï¼Œæœ€ä½³æ¨¡å‹ï¼ˆTITAN-CONCHä¸ResNet-18ï¼‰æ¥è¿‘è°ƒæ•´åçš„Leibovichè¯„åˆ†ï¼Œå±•ç¤ºäº†æ˜¾è‘—çš„æ€§èƒ½æå‡ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬è‚¾ç™Œæ‚£è€…çš„ä¸ªæ€§åŒ–æ²»ç–—æ–¹æ¡ˆåˆ¶å®šå’Œæœ¯åç›‘æµ‹ï¼Œèƒ½å¤Ÿä¸ºä¸´åºŠåŒ»ç”Ÿæä¾›æ›´ä¸ºç²¾å‡†çš„å¤å‘é£é™©è¯„ä¼°ï¼Œè¿›è€Œä¼˜åŒ–æ‚£è€…çš„æ²»ç–—ç­–ç•¥ï¼Œæå‡ç”Ÿå­˜ç‡ã€‚æœªæ¥ï¼Œç ”ç©¶è¿˜å¯æ‰©å±•è‡³å…¶ä»–ç±»å‹ç™Œç—‡çš„å¤šæ¨¡æ€èåˆé£é™©é¢„æµ‹ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Recurrence risk estimation in clear cell renal cell carcinoma (ccRCC) is essential for guiding postoperative surveillance and treatment. The Leibovich score remains widely used for stratifying distant recurrence risk but offers limited patient-level resolution and excludes imaging information. This study evaluates multimodal recurrence prediction by integrating preoperative computed tomography (CT) and postoperative histopathology whole-slide images (WSIs). A modular deep learning framework with pretrained encoders and Cox-based survival modeling was tested across unimodal, late fusion, and intermediate fusion setups. In a real-world ccRCC cohort, WSI-based models consistently outperformed CT-only models, underscoring the prognostic strength of pathology. Intermediate fusion further improved performance, with the best model (TITAN-CONCH with ResNet-18) approaching the adjusted Leibovich score. Random tie-breaking narrowed the gap between the clinical baseline and learned models, suggesting discretization may overstate individualized performance. Using simple embedding concatenation, radiology added value primarily through fusion. These findings demonstrate the feasibility of foundation model-based multimodal integration for personalized ccRCC risk prediction. Future work should explore more expressive fusion strategies, larger multimodal datasets, and general-purpose CT encoders to better match pathology modeling capacity.

